Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan Biomaterial Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	184.27	258.41	205.34	171.68	183.15	91.65
Short-Term Investments	62.5	97.5	107.5	132.5	149.5	61
Cash & Short-Term Investments	246.77	355.91	312.84	304.18	332.65	152.65
Cash Growth	-28.04%	13.76%	2.85%	-8.56%	117.92%	-26.86%
Accounts Receivable	29.8	36.05	11.92	14.39	16.04	2.4
Other Receivables	0.73	0.91	0.6	0.5	0.25	0.01
Receivables	30.53	36.96	12.52	14.89	16.29	2.41
Inventory	89.48	59.35	40.59	48.43	17.8	9.98
Prepaid Expenses	34	16.67	5.35	4.04	7.75	11.1
Total Current Assets	400.78	468.88	371.3	371.54	374.49	176.14
Property, Plant & Equipment	272.51	271.54	325.37	336.39	351.49	363.35
Long-Term Investments	0.19	-	-	0.09	0.06	0.04
Other Intangible Assets	1.57	1.73	1.28	1.58	2.37	1.98
Other Long-Term Assets	56.07	47.8	6.6	6.68	6.91	12.28
Total Assets	731.12	789.95	704.56	716.28	735.31	553.79

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.18	20.25	4.7	8.25	3.62	6.65
Accrued Expenses	-	22.81	12.3	14.02	11.92	12.6
Current Portion of Leases	4.65	4.46	4.4	5.18	7.22	6.88
Current Income Taxes Payable	-	-	-	1.1	-	-
Current Unearned Revenue	0.04	0.76	0.47	-	-	-
Other Current Liabilities	26.23	6.71	3.93	4.33	4.49	37.37
Total Current Liabilities	38.1	54.99	25.81	32.87	27.25	63.5
Long-Term Leases	47.43	48.13	52.59	55.52	61.29	67.04
Other Long-Term Liabilities	1.74	1.74	-	-	0.35	0.35
Total Liabilities	87.27	104.86	78.4	88.38	88.89	130.89

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	420	420	420	420	420	330
Additional Paid-In Capital	192.67	192.67	192.67	192.67	192.67	265.98
Retained Earnings	31.18	72.42	13.49	15.23	33.76	-174.11
Comprehensive Income & Other	-	-	-	-	-	1.03
Shareholders' Equity	643.85	685.09	626.16	627.89	646.42	422.89
Total Liabilities & Equity	731.12	789.95	704.56	716.28	735.31	553.79

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	52.07	52.59	56.99	60.7	68.51	73.92
Net Cash (Debt)	194.7	303.32	255.85	243.48	264.14	78.73
Net Cash Growth	-32.42%	18.55%	5.08%	-7.82%	235.51%	-40.61%
Net Cash Per Share	4.87	7.22	6.09	5.80	6.46	2.39
Filing Date Shares Outstanding	62.2	42	42	42	42	33
Total Common Shares Outstanding	62.2	42	42	42	42	33
Working Capital	362.68	413.89	345.5	338.67	347.24	112.64
Book Value Per Share	10.35	16.31	14.91	14.95	15.39	12.81
Tangible Book Value	642.28	683.36	624.88	626.31	644.06	420.92
Tangible Book Value Per Share	10.33	16.27	14.88	14.91	15.33	12.76
Buildings	-	223.2	267.85	267.85	267.85	-
Machinery	-	55.81	53.51	49.68	50.71	48.87
Construction In Progress	-	-	-	-	-	267.85

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error